High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study

High clinician- and patient-reported satisfaction with individualized onabotulinumtoxinA treatment for spasticity across several etiologies from the ASPIRE study

Etiology-specific onabotulinumtoxinA utilization to manage spasticity is largely unknown. In this 1-year interim analysis, we evaluated real-world onabotulinumtoxinA utilization and effectiveness across several etiologies from the Adult Spasticity International Registry (ASPIRE) study. ASPIRE is a m...

Full description

Bibliographic Details
Main Authors: Gerard E. Francisco, Daniel S. Bandari, Ganesh Bavikatte, Wolfgang H. Jost, Emily McCusker, Joan Largent, Aleksej Zuzek, Alberto Esquenazi
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:Toxicon: X
Subjects:
Botulinum toxins
Type A
Cerebral palsy
Cerebrovascular accident
Disability evaluation
Electrical stimulation
Online Access:http://www.sciencedirect.com/science/article/pii/S2590171020300187

Internet

http://www.sciencedirect.com/science/article/pii/S2590171020300187

Similar Items